Monitoring of Short-Term Erythropoietin Therapy in Rats with Acute Spinal Cord Injury Using Manganese-Enhanced Magnetic Resonance Imaging

Journal of Neuroimaging

Volumn 25, Issue 4, 2015, Pages 582-589

  Freitag, Martin Thomas ^a   Márton, Gábor ^b   Pajer, Krisztián ^b   Hartmann, Jens ^c   Walder, Nadja ^c   Rossmann, Markus ^c   Parzer, Peter ^d   Redl, Heinz ^c   Nógrádi, Antal ^b,c   Stieltjes, Bram ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF SZEGED   (Hungary)

^c LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Apoptosis; EPO; Inflammation; Neuroprotection; Neuroregeneration; Spinal cord injury

Indexed keywords

MANGANESE; MANGANESE CHLORIDE; RECOMBINANT ERYTHROPOIETIN; CHLORIDE; CONTRAST MEDIUM; ERYTHROPOIETIN; MANGANESE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BBB SCORING; BLOOD BRAIN BARRIER; CELL COUNT; CISTERNA MAGNA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; DRUG EFFICACY; HISTOPATHOLOGY; LAMINECTOMY; LOCOMOTION; MALE; MANGANESE ENHANCED MAGNETIC RESONANCE IMAGING; MICROGLIA; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; RAT; SCORING SYSTEM; SIGNAL NOISE RATIO; SPINAL CORD; SPINAL CORD INJURY; THORACIC SPINAL CORD; TREATMENT DURATION; ACUTE DISEASE; ANIMAL; DRUG MONITORING; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; CHLORIDES; CONTRAST MEDIA; DRUG MONITORING; ERYTHROPOIETIN; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 84937027295     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12202     Document Type: Article

References (22)

1. Casha S, Zygun D, McGowan MD, Yong VW, Hurlbert RJ, et al. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain 2012;135:1224-1236.
2. Lombardero M, Kovacs K, Scheithauer BW. Erythropoietin: a hormone with multiple functions. Pathobiology 2011;78:41-53.
3. Sargin D, Friedrichs H, El-Kordi A, et al. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol 24:573-594.
4. Marti HH, Bernaudin M, Petit E, et al. Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia. News Physiol Sci 2000;15:225-229.
5. Kaptanoglu E, Solaroglu I, Okutan O, et al. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 2004;27:113-120.
6. Wang L, Zhang Z, Wang Y, et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004;35:1732-1737.
7. Kretz A, Happold CJ, Marticke JK, et al. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci 2005;29:569-579.
8. Bilgen M, Dancause N, Al-Hafez B, et al. Manganese-enhanced MRI of rat spinal cord injury. Magn Reson Imaging 2005;23:829-832.
9. Martirosyan NL, Bennett KM, Theodore N, et al. Manganese-enhanced magnetic resonance imaging in experimental spinal cord injury: correlation between T1-weighted changes and Mn(2+) concentrations. Neurosurgery 2010;66:131-136.
10. Walder N, Petter-Puchner AH, Brejnikow M, et al. Manganese enhanced magnetic resonance imaging in a contusion model of spinal cord injury in rats: correlation with motor function. Invest Radiol 2008;43:277-283.
11. Stieltjes B, Klussmann S, Bock M, et al. Manganese-enhanced magnetic resonance imaging for in vivo assessment of damage and functional improvement following spinal cord injury in mice. Magn Reson Med 2006;55:1124-1131.
12. Sloot WN, Gramsbergen JB. Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 1994;657:124-132.
13. Pautler RG, Silva AC, Koretsky AP. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 1998;40:740-748.
14. Narita K, Kawasaki F, Kita H. Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Res 1990;510:289-295.
15. Pautler RG, Mongeau R, Jacobs RE. In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI). Magn Reson Med 2003;50:33-39.
16. Aschner M, Aschner JL. Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci Biobehav Rev 1991;15:333-340.
17. Liu CH, D'Arceuil HE, de Crespigny AJ. Direct CSF injection of MnCl(2) for dynamic manganese-enhanced MRI. Magn Reson Med 2004;51:978-987.
18. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12:1-21.
19. IBM. SPSS Statistics. Release 20:2011.
20. Leal-Filho MB. Spinal cord injury: from inflammation to glial scar. Surg Neurol Int 2011;2:112.
21. Moller T. Calcium signaling in microglial cells. Glia 2002;40:184-194.
22. 2+ channels. Am J Physiol 1994;266:C1650-C1655.